According to a report,“Nanomedicine Market Analysis By Products, (Therapeutics, Regenerative Medicine, Diagnostics), By Application, (Clinical Oncology, Infectious diseases), By Nanomolecule (Gold, Silver, Iron Oxide, Alumina), & Segment Forecasts, 2018 – 2025” , published by Grand View Research, Inc., The global nanomedicine market is anticipated to reach USD 350.8 billion by 2025. Application of nanotechnology-based contrast reagents for diagnosis and monitoring of the effects of drugs on an unprecedented short timescale is also attributive drive growth in the coming years. Additionally, demand for biodegradable implants with longer lifetimes that enable tissue restoration is anticipated to influence demand. As per the WHO factsheet, cancer is found to be one of the major causes of mortality and morbidity worldwide, with approximately 14 million new cases in 2012 and 8.2 million cancer-related deaths.
Key Takeaways from the report:
U.S. nanomedicine market by products, 2013 – 2025 (USD Billion)
Browse More Reports in Pharmaceuticals Industry:
Pruritus Therapeutics Market: Growing worldwide prevalence of atopic dermatitis, allergic contact dermatitis and urticaria is expected to drive market growth during the forecast period. Introduction of new products based on scientific mechanistic understanding such as the identification of new T-cell subsets, particularly Th17, and Th22 and the patent expiration of PROTOPIC (tacrolimus) is expected to open up new avenues for manufacturers to capitalize on over the forecast period.
Atrial fibrillation market: Rising occurrence of strokes, brain damage and atrial fibrillation owing to blood clots along with an increasing geriatric population is expected to drive industry growth.
Solutions such as nanoformulations with triggered release for tailor-made pharmacokinetics, nanoparticles for local control of tumor in combination with radiotherapy, and functionalized nanoparticles for targeted in-vivo activation of stem cell production are anticipated to drive R&D, consequently resulting in revenue generation in the coming years.
Nanomedicine market, by region, 2016 (%)
Biopharmaceutical and medical devices companies are actively engaged in development of novel products as demonstrated by the increasingly growing partnerships between leading enterprises and nanomedicine startups. For instance, in November 2015, Ablynx and Novo Nordisk signed a global collaboration and a licensing agreement for development and discovery of innovative drugs with multi-specific nanobodies. This strategic partnership is anticipated to rise the net annual sales of the products uplifting the market growth.
However, in contrary with the applications of nanotechnology, the entire process of lab to market approval is a tedious and expensive one with stringent regulatory evaluation involved thereby leading investors to remain hesitant for investments.
Grand View Research has segmented the nanomedicine market on the basis of product, application, nanomolecule type, and region:
Nanomedicine Product Outlook (Revenue, USD Billion; 2013 – 2025)
Therapeutics
Regenerative medicine
In-vitro diagnostics
In-vivo diagnostics
Vaccines
Nanomedicine Application Outlook (Revenue, USD Billion; 2013 – 2025)
Clinical Oncology
Infectious diseases
Clinical Cardiology
Orthopedics
Others
Nanomedicine Nanomolecule Type Outlook (Revenue, USD Billion; 2013 – 2025)
Nanoparticles
Metal & Metal Oxide Nanoparticles
By Type
Gold Nanoparticles
Silver Nanoparticles
Iron Oxide Nanoparticles
Alumina Nanoparticles
Gadolinium Oxide Nanoparticles
By Application
In-vivo Imaging
Targeted Drug Delivery
Proton Therapy
In-vitro assays
Cell & Phantom Imaging
Liposomes
Polymers & polymer drug conjugates
Hydrogel nanoparticles
Dendrimers
Inorganic nanoparticles
Nanoshells
Nanotubes
Nanodevices
Nanomedicine Regional Outlook (Revenue, USD Billion; 2013 – 2025)
North America
U.S.
Canada
Europe
Germany
UK
Asia Pacific
Japan
China
Latin America
Brazil
Middle East and Africa (MEA)
South Africa
Explore the BI enabled intuitive market research database, Navigate with Grand View Compass, by Grand View Research, Inc.
About Grand View Research
Grand View Research provides syndicated as well as customized research reports and consulting services on 46 industries across 25 major countries worldwide. This U.S.-based market research and consulting company is registered in California and headquartered in San Francisco. Comprising over 425 analysts and consultants, the company adds 1200+ market research reports to its extensive database each year. Supported by an interactive market intelligence platform, the team at Grand View Research guides Fortune 500 companies and prominent academic institutes in comprehending the global and regional business environment and carefully identifying future opportunities.
For more information: www.grandviewresearch.com
Media ContactCompany Name: Grand View Research, Inc.Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.Email: Send EmailPhone: 1-415-349-0058, Toll Free: 1-888-202-9519Address:201, Spear Street, 1100 City: San FranciscoState: CaliforniaCountry: United StatesWebsite: www.grandviewresearch.com/industry-analysis/nanomedicine-market